-
Velpatasvir is an NS5A
inhibitor (by Gilead)
which is used
together with
sofosbuvir in the
treatment of
hepatitis C
infection of all six
major genotypes...
- Sofosbuvir/
velpatasvir, sold
under the
brand name
Epclusa among others, is a fixed-dose
combination medication for the
treatment of
hepatitis C in adults...
- Sofosbuvir/
velpatasvir/voxilaprevir, sold
under the
brand name Vosevi, is a fixed-dose
combination medication for the
treatment of
hepatitis C. It combines...
- or 12 w****s of sofosbuvir/
velpatasvir, or if
certain antiviral mutations are present, 12 w****s of sofosbuvir/
velpatasvir/voxilaprevir (when
certain antiviral...
-
first generics. The company's
commercially available products include velpatasvir/sofosbuvir, sofosbuvir/daclatasvir, osimertinib, crizotinib, daclatasvir...
- (glecaprevir + pibrentasvir)
Ravidasvir Sofosbuvir Sofosbuvir/
velpatasvir (sofosbuvir +
velpatasvir) Ledipasvir/sofosbuvir (ledipasvir + sofosbuvir) Ribavirin...
- (sofosbuvir and ledipasvir)
Epclusa (sofosbuvir and
velpatasvir)
Vosevi (sofosbuvir,
velpatasvir, and voxilaprevir)
Zepatier (elbasvir and grazoprevir)...
-
inhibitor (by Gilead) that is used in
combination with
sofosbuvir and
velpatasvir. The
combination has the
trade name
Vosevi and
received a
positive opinion...
- Glecaprevir/pibrentasvir Ledipasvir/sofosbuvir# Ombitasvir/paritaprevir/ritonavir# Sofosbuvir/daclatasvir Sofosbuvir/
velpatasvir# Sofosbuvir/
velpatasvir/voxilaprevir...
- Afdhal;
Stuart K Roberts; et al. (17
November 2015). "Sofosbuvir and
Velpatasvir for HCV
Genotype 2 and 3 Infection". The New
England Journal of Medicine...
